Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) FCF Margin (2019 - 2025)

Pulmonx (LUNG) has disclosed FCF Margin for 7 consecutive years, with 37.67% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin fell 567.0% to 37.67% in Q3 2025 year-over-year; TTM through Sep 2025 was 36.23%, a 601.0% increase, with the full-year FY2024 number at 39.32%, up 1559.0% from a year prior.
  • FCF Margin was 37.67% for Q3 2025 at Pulmonx, down from 16.66% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 16.66% in Q2 2025 to a low of 143.55% in Q1 2022.
  • A 5-year average of 63.68% and a median of 58.92% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: soared 9896bps in 2021, then crashed -3736bps in 2022.
  • Pulmonx's FCF Margin stood at 74.63% in 2021, then increased by 21bps to 58.92% in 2022, then increased by 26bps to 43.84% in 2023, then grew by 24bps to 33.25% in 2024, then fell by -13bps to 37.67% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's FCF Margin are 37.67% (Q3 2025), 16.66% (Q2 2025), and 58.71% (Q1 2025).